The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BIO-PATH HOLDINGS INC | COM | 09057N102 | 6,857 | 3,830,882 | SH | SOLE | 0 | 3,830,882 | 0 | 0 | |
EQUIFAX INC. | COM | 294429105 | 3 | 29 | SH | SOLE | 0 | 29 | 0 | 0 | |
GENERAL MOLY INC | COM | 370373102 | 1,491 | 2,922,831 | SH | SOLE | 0 | 2,922,831 | 0 | 0 | |
INTREXON CORPORATION | COM | 46122T102 | 95,281 | 2,100,085 | SH | SOLE | 0 | 2,100,085 | 0 | 0 | |
KINDER MORGAN INC/DE | COM | 49456B101 | 50 | 1,200 | SH | SOLE | 0 | 1,200 | 0 | 0 | |
LEXICON PHARMACEUTICALS INC | COM | 528872104 | 236 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
PORTLAND GENERAL ELECTRIC CO | COM | 736508847 | 4 | 118 | SH | SOLE | 0 | 118 | 0 | 0 | |
SPDR GOLD TRUST | ETFS | 78463V107 | 1,753 | 15,422 | SH | SOLE | 0 | 15,422 | 0 | 0 | |
TEXAS INSTRUMENTS INC | COM | 882508104 | 1,830 | 32,000 | SH | SOLE | 0 | 32,000 | 0 | 0 | |
VANGUARD 500 INDEX FUND | ETFS | 922908363 | 3,118 | 16,482 | SH | SOLE | 0 | 16,482 | 0 | 0 | |
VANGUARD ENERGY ETF | ETFS | 92204A306 | 1,870 | 17,109 | SH | SOLE | 0 | 17,109 | 0 | 0 | |
VANGUARD FTSE DEV MKTS | ETFS | 921943858 | 2,607 | 65,465 | SH | SOLE | 0 | 65,465 | 0 | 0 | |
VANGUARD MID-CAP VALUE ETF | ETFS | 922908512 | 2,423 | 26,362 | SH | SOLE | 0 | 26,362 | 0 | 0 | |
VANGUARD MSCI EMERGING MKTS | ETFS | 922042858 | 2,484 | 60,789 | SH | SOLE | 0 | 60,789 | 0 | 0 | |
VANGUARD REIT ETF | ETFS | 922908553 | 1,560 | 18,503 | SH | SOLE | 0 | 18,503 | 0 | 0 | |
VITAE PHARMACEUTICALS INC | COM | 92847N103 | 130 | 11,100 | SH | SOLE | 0 | 11,100 | 0 | 0 | |
WILLIAMS PARTNERS LP | LP - PUBLIC EQUITY | 96949L105 | 8,502 | 172,732 | SH | SOLE | 0 | 172,732 | 0 | 0 | |
ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 126,248 | 11,722,163 | SH | SOLE | 0 | 11,722,163 | 0 | 0 |